USK Tri-Axis Balanced Series I-NP

Solanum lycopersicum

Tomato

Tier IUSK Tri-Axis Balanced Series

Target Trait

1×

fold-change

Umami+Sweet+Kokumi balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-02505

Genomic Edits

GC Content

46.7%

Construct Length

3,932 bp

Promoter System

Lipid nanoparticle / Ubiquitin

Expression System

Nanoparticle delivery

Host Strain

LNP-mediated

Receptor Target

mGluR1 + TAS1R2/TAS1R3 + CaSR

IFI Score

100

Pathway Edits

mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent USK pathway operation
Cross-pathway regulatory circuit for balanced USK triple-axis expression

Key Interventions

Triple-axis receptor co-activation: mGluR1, TAS1R2/TAS1R3, and CaSR pathways simultaneously engineeredBalanced tri-axis expression strategy (USK) with cross-pathway flux managementLNP-mediated delivery of triple-axis mRNA panel for transient expression profiling

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier I USK triple-axis construct for advanced multi-modal sensory architecture combining umami, sweet, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$549 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities